Coronary heart disease (CHD) is one of the most common heart diseases worldwide and is currently grouped into two syndromes: acute coronary syndrome (ACS) and chronic coronary syndrome (CCS). Following revascularization, patients with ACS and CCS are usually treated in the medium and long term by both general practitioners and cardiologists. The current guidelines of the European Society of Cardiology (ESC) emphasize that the assessment of the individual ischemia and bleeding risk is an important basis for the choice of an adequate antithrombotic strategy.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Long-term study with dementia patients
Ginkgo biloba extract significantly reduces the risk of progression
- Intestinal microbiome
Complex and fragile system of microorganisms
- Cancer prevention
Poorer prognosis for men who avoid prostate cancer screening
- Diabetes mellitus
Treatment of comorbidities in older people
- Liver steatosis with metabolic dysfunction
New nomenclature for non-alcoholic fatty liver disease
- Type 2 diabetes: PAD and diabetic foot syndrome
Prevention is better than cure – don’t miss the risk foot
- Prostate cancer
High-resolution ultrasound could diagnose prostate cancer faster
- Chronic lung diseases